Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.52 |
| ▸ | CA2 | P00918 | 6/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
| ▸ | RECQL | P46063 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.45 |
| ▸ | TSHR | P16473 | 4/20 | 0.45 |
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL438255 | 1.00 | ALDH1A1 (0.52) | ALDH1A1CA2TDP1RECQLCYP3A4 | |
| Calcium SCHEMBL1526989 | 0.98 | ALDH1A1 (0.50) | ALDH1A1CA2TDP1RECQLCYP3A4 | |
| SCHEMBL125029 | 0.98 | ALDH1A1 (0.50) | ALDH1A1CA2TDP1RECQLCYP3A4 | |
| Ammonia Solution, Strong SCHEMBL28809344 | 0.98 | ALDH1A1 (0.50) | ALDH1A1CA2TDP1RECQLCYP3A4 | |
| Fluoride SCHEMBL28530943 | 0.98 | ALDH1A1 (0.50) | ALDH1A1CA2TDP1RECQLCYP3A4 | |
| SCHEMBL3468193 | 0.98 | ALDH1A1 (0.50) | ALDH1A1CA2TDP1RECQLCYP3A4 | |
| Fluoride SCHEMBL4338249 | 0.96 | ALDH1A1 (0.48) | ALDH1A1CA2TDP1RECQLCYP3A4 | |
| SCHEMBL8810590 | 0.94 | TP53 (0.48) | ALDH1A1CA2TDP1RECQLCYP3A4 | |
| SCHEMBL8437242 | 0.92 | LMNA (0.48) | ALDH1A1CA2TDP1RECQLCYP3A4 | |
| SCHEMBL3460439 | 0.92 | LMNA (0.48) | ALDH1A1CA2TDP1RECQLCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11446398-B2 | Regulated biocircuit systems | OBSIDIAN THERAPEUTICS, INC. (US) | 2022-09-20 | — | — | US | disclosed |
| US-20210254056-A1 | IDENTIFICATION AND TARGETED MODULATION OF GENE SIGNALING NETWORKS | CAMP4 THERAPEUTICS CORPORATION | 2021-08-19 | — | — | US | disclosed |